Key result
Intra-arterial bolus injections of atrial natriuretic factor caused graded increases in hepatic arterial blood flow without altering portal inflow resistance.
ANF selectively dilates the hepatic arterial bed without affecting portal inflow resistance, potentially favoring trans-sinusoidal fluid exchange.
Answers are grounded in this paper and cite their sources.
Should not change clinical practice; leaves open ANF selectivity for hepatic arterial flow in human studies.
The vascular actions of atrial natriuretic factor (ANF) have been assessed with other vasoactive agents on the hepatic arterial and portal vascular beds of the anaesthetized dog. 2. Intra-arterial bolus injections of ANF (0.1-50 nmol) caused graded increases in hepatic arterial blood flow representing a vasodilatation of relatively short duration. Vasoconstriction was never observed. 3. The maximum increase in hepatic arterial blood was the same for ANF and isoprenaline (Iso) i.e. approximately 60-70% increase over control flow. 4. On a molar basis, ANF was less potent than Iso although over the higher dose range (10(-9)-10(-7) mol) its vasodilator activity exceeded that of the endogenous vasodilator adrenaline. 5. Intraportal bolus injections (1.0-50 nmol) of ANF did not alter portal inflow resistance since no changes in portal inflow pressure occurred when the portal circuit was perfused at constant inflow volume. 6. This differential action of ANF on the hepatic arterial and portal vascular beds may provide a change in total liver blood flow in favour of the arterial component. 7. ANF, by altering hepatic haemodynamics to favour formation of trans-sinusoidal fluid exchange, may provide a temporary expansion of the extravascular fluid reservoir to buffer any increased venous pressure. However, chronically elevated plasma levels of ANF would encourage the formation of ascitic fluid.
No takes yet. Share an insight, caveat, or question.
Withrington et al. (1990) studied this question. Atrial natriuretic factor (ANF) vs. Isoprenaline and adrenaline was evaluated on Hepatic arterial blood flow and portal inflow resistance. Intra-arterial bolus injections of atrial natriuretic factor caused graded increases in hepatic arterial blood flow without altering portal inflow resistance.
Synapse has enriched 10 related papers. Consider them for comparative context: